Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 480 entries
Sorted by: Best Match Show Resources per page
Can clinical interventions change care at the end of life?

education interventions

Danis M.
GSID: Q_uESJN2fXUJ
LC Hanson, JA Tulsky, M Danis - Annals of Internal Medicine, 1997 - acpjournals.org

… All interventions provided patients with education about life-sustaining treatments and their right to express preferences about use of these … All other successful studies in this group used patient-education materials and discussions with a physician or other clinician....

Cite
Hanson, L. C., Tulsky, J. A., & Danis, M. (1997). Can clinical interventions change care at the end of life?. Annals of Internal Medicine, 126(5), 381-388.
Hanson, Laura C., James A. Tulsky, and Marion Danis. "Can clinical interventions change care at the end of life?." Annals of Internal Medicine 126.5 (1997): 381-388.
Copy Download .nbib Format: MLA
E-textiles for educators: Participatory simulations with e-puppetry

after-school settings

Danish J, Peppler K.
GSID: _o4Zi3T9MQ4J
K Peppler, J Danish - … messages: Dispatches from the world of e …, 2013 - kyliepeppler.com

Most of the previous chapters presented examples of how students can develop their own products and programs using the l.. ilyl'ad Arduino (Buechley and Eisenberg 2008) to learn …

Cite
Peppler, K., & Danish, J. (2013). E-textiles for educators: Participatory simulations with e-puppetry. Textile messages: Dispatches from the world of e-textiles and education, 133-141.
Peppler, K., and J. Danish. "E-textiles for educators: Participatory simulations with e-puppetry." Textile messages: Dispatches from the world of e-textiles and education (2013): 133-141.
Copy Download .nbib Format: MLA
Health disparities in colorectal cancer among racial and ethnic minorities in the United States.

Journal of gastrointestinal oncology

Jackson CS, Oman M, Patel AM, Vega KJ.
PMID: 27034811
J Gastrointest Oncol. 2016 Apr;7:S32-43. doi: 10.3978/j.issn.2078-6891.2015.039.

In the 2010 Census, just over one-third of the United States (US) population identified themselves as being something other than being non-Hispanic white alone. This group has increased in size from 86.9 million in 2000 to 111.9 million in...

Cite
Jackson CS, Oman M, Patel AM, et al. Health disparities in colorectal cancer among racial and ethnic minorities in the United States. J Gastrointest Oncol. 2016;7:S32-43doi: 10.3978/j.issn.2078-6891.2015.039.
Jackson, C. S., Oman, M., Patel, A. M., & Vega, K. J. (2016). Health disparities in colorectal cancer among racial and ethnic minorities in the United States. Journal of gastrointestinal oncology, 7S32-43. https://doi.org/10.3978/j.issn.2078-6891.2015.039
Jackson, Christian S, et al. "Health disparities in colorectal cancer among racial and ethnic minorities in the United States." Journal of gastrointestinal oncology vol. 7 (2016): S32-43. doi: https://doi.org/10.3978/j.issn.2078-6891.2015.039
Jackson CS, Oman M, Patel AM, Vega KJ. Health disparities in colorectal cancer among racial and ethnic minorities in the United States. J Gastrointest Oncol. 2016 Apr;7:S32-43. doi: 10.3978/j.issn.2078-6891.2015.039. PMID: 27034811; PMCID: PMC4783613.
Copy Download .nbib Format: NLM
Synergistic effect of haloduracin and chloramphenicol against clinically important Gram-positive bacteria.

Biotechnology reports (Amsterdam, Netherlands)

Danesh A, Ljungh Å, Mattiasson B, Mamo G.
PMID: 28352561
Biotechnol Rep (Amst). 2016 Dec 27;13:37-41. doi: 10.1016/j.btre.2016.12.008. eCollection 2017 Mar.

The emergence of drug-resistant pathogens has triggered the search for more efficient antimicrobial agents and formulations for treatment of infections. In recent years, combination therapy has become one of the effective clinical practices in treating infections. The present study...

Cite
Danesh A, Ljungh Å, Mattiasson B, et al. Synergistic effect of haloduracin and chloramphenicol against clinically important Gram-positive bacteria. Biotechnol Rep (Amst). 2016;13:37-41doi: 10.1016/j.btre.2016.12.008.
Danesh, A., Ljungh, �. �., Mattiasson, B., & Mamo, G. (2017). Synergistic effect of haloduracin and chloramphenicol against clinically important Gram-positive bacteria. Biotechnology reports (Amsterdam, Netherlands), 1337-41. https://doi.org/10.1016/j.btre.2016.12.008
Danesh, Abolghasem, et al. "Synergistic effect of haloduracin and chloramphenicol against clinically important Gram-positive bacteria." Biotechnology reports (Amsterdam, Netherlands) vol. 13 (2017): 37-41. doi: https://doi.org/10.1016/j.btre.2016.12.008
Danesh A, Ljungh Å, Mattiasson B, Mamo G. Synergistic effect of haloduracin and chloramphenicol against clinically important Gram-positive bacteria. Biotechnol Rep (Amst). 2016 Dec 27;13:37-41. doi: 10.1016/j.btre.2016.12.008. eCollection 2017 Mar. PMID: 28352561; PMCID: PMC5361133.
Copy Download .nbib Format: NLM
Enhancement effects of chelating agents on the degradation of tetrachloroethene in Fe(III) catalyzed percarbonate system.

Chemical engineering journal (Lausanne, Switzerland : 1996)

Miao Z, Gu X, Lu S, Brusseau ML, Zhang X, Fu X, Danish M, Qiu Z, Sui Q.
PMID: 26549979
Chem Eng J. 2015 Dec 01;281:286-294. doi: 10.1016/j.cej.2015.06.076. Epub 2015 Jun 23.

The performance of Fe(III)-based catalyzed sodium percarbonate (SPC) for stimulating the oxidation of tetrachloroethene (PCE) for groundwater remediation applications was investigated. The chelating agents citric acid monohydrate (CIT), oxalic acid (OA), and Glutamic acid (Glu) significantly enhanced the degradation...

Cite
Miao Z, Gu X, Lu S, et al. Enhancement effects of chelating agents on the degradation of tetrachloroethene in Fe(III) catalyzed percarbonate system. Chem Eng J. 2015;281:286-294doi: 10.1016/j.cej.2015.06.076.
Miao, Z., Gu, X., Lu, S., Brusseau, M. L., Zhang, X., Fu, X., Danish, M., Qiu, Z., & Sui, Q. (2015). Enhancement effects of chelating agents on the degradation of tetrachloroethene in Fe(III) catalyzed percarbonate system. Chemical engineering journal (Lausanne, Switzerland : 1996), 281286-294. https://doi.org/10.1016/j.cej.2015.06.076
Miao, Zhouwei, et al. "Enhancement effects of chelating agents on the degradation of tetrachloroethene in Fe(III) catalyzed percarbonate system." Chemical engineering journal (Lausanne, Switzerland : 1996) vol. 281 (2015): 286-294. doi: https://doi.org/10.1016/j.cej.2015.06.076
Miao Z, Gu X, Lu S, Brusseau ML, Zhang X, Fu X, Danish M, Qiu Z, Sui Q. Enhancement effects of chelating agents on the degradation of tetrachloroethene in Fe(III) catalyzed percarbonate system. Chem Eng J. 2015 Dec 01;281:286-294. doi: 10.1016/j.cej.2015.06.076. Epub 2015 Jun 23. PMID: 26549979; PMCID: PMC4634672.
Copy Download .nbib Format: NLM
Enabling low amounts of YAG:Ce(3+) to convert blue into white light with plasmonic Au nanoparticles.

Nanoscale

Hussain T, Zhong L, Danesh M, Ye H, Liang Z, Xiao D, Qiu CW, Lou C, Chi L, Jiang L.
PMID: 26006187
Nanoscale. 2015 Jun 21;7(23):10350-6. doi: 10.1039/c5nr01038a.

We report a new strategy to directly attach Au nanoparticles onto YAG:Ce(3+) phosphor via a chemical preparation method, which yields efficient and quality conversion of blue to yellow light in the presence of a low amount of phosphor. Photoluminescent...

Cite
Hussain T, Zhong L, Danesh M, et al. Enabling low amounts of YAG:Ce(3+) to convert blue into white light with plasmonic Au nanoparticles. Nanoscale. 2015;7(23):10350-6doi: 10.1039/c5nr01038a.
Hussain, T., Zhong, L., Danesh, M., Ye, H., Liang, Z., Xiao, D., Qiu, C. W., Lou, C., Chi, L., & Jiang, L. (2015). Enabling low amounts of YAG:Ce(3+) to convert blue into white light with plasmonic Au nanoparticles. Nanoscale, 7(23), 10350-6. https://doi.org/10.1039/c5nr01038a
Hussain, Talib, et al. "Enabling low amounts of YAG:Ce(3+) to convert blue into white light with plasmonic Au nanoparticles." Nanoscale vol. 7,23 (2015): 10350-6. doi: https://doi.org/10.1039/c5nr01038a
Hussain T, Zhong L, Danesh M, Ye H, Liang Z, Xiao D, Qiu CW, Lou C, Chi L, Jiang L. Enabling low amounts of YAG:Ce(3+) to convert blue into white light with plasmonic Au nanoparticles. Nanoscale. 2015 Jun 21;7(23):10350-6. doi: 10.1039/c5nr01038a. PMID: 26006187.
Copy Download .nbib Format: NLM
Kidney Disease Among Registered Métis Citizens of Ontario: A Population-Based Cohort Study.

Canadian journal of kidney health and disease

Hayward JS, McArthur E, Nash DM, Sontrop JM, Russell SJ, Khan S, Walker JD, Nesrallah GE, Sood MM, Garg AX.
PMID: 28491337
Can J Kidney Health Dis. 2017 Apr 11;4:2054358117703071. doi: 10.1177/2054358117703071. eCollection 2017.

BACKGROUND: Indigenous peoples in Canada have higher rates of kidney disease than non-Indigenous Canadians. However, little is known about the risk of kidney disease specifically in the Métis population in Canada.OBJECTIVE: To compare the prevalence of chronic kidney disease...

Cite
Hayward JS, McArthur E, Nash DM, et al. Kidney Disease Among Registered Métis Citizens of Ontario: A Population-Based Cohort Study. Can J Kidney Health Dis. 2017;4:2054358117703071doi: 10.1177/2054358117703071.
Hayward, J. S., McArthur, E., Nash, D. M., Sontrop, J. M., Russell, S. J., Khan, S., Walker, J. D., Nesrallah, G. E., Sood, M. M., & Garg, A. X. (2017). Kidney Disease Among Registered Métis Citizens of Ontario: A Population-Based Cohort Study. Canadian journal of kidney health and disease, 42054358117703071. https://doi.org/10.1177/2054358117703071
Hayward, Jade S, et al. "Kidney Disease Among Registered Métis Citizens of Ontario: A Population-Based Cohort Study." Canadian journal of kidney health and disease vol. 4 (2017): 2054358117703071. doi: https://doi.org/10.1177/2054358117703071
Hayward JS, McArthur E, Nash DM, Sontrop JM, Russell SJ, Khan S, Walker JD, Nesrallah GE, Sood MM, Garg AX. Kidney Disease Among Registered Métis Citizens of Ontario: A Population-Based Cohort Study. Can J Kidney Health Dis. 2017 Apr 11;4:2054358117703071. doi: 10.1177/2054358117703071. eCollection 2017. PMID: 28491337; PMCID: PMC5406217.
Copy Download .nbib Format: NLM
Characterization of genetically engineered mouse models carrying Col2a1-cre-induced deletions of Lrp5 and/or Lrp6.

Bone research

Schumacher CA, Joiner DM, Less KD, Drewry MO, Williams BO.
PMID: 26962465
Bone Res. 2016 Mar 01;4:15042. doi: 10.1038/boneres.2015.42. eCollection 2016.

Mice carrying Collagen2a1-cre-mediated deletions of Lrp5 and/or Lrp6 were created and characterized. Mice lacking either gene alone were viable and fertile with normal knee morphology. Mice in which both Lrp5 and Lrp6 were conditionally ablated via Collagen2a1-cre-mediated deletion displayed...

Cite
Schumacher CA, Joiner DM, Less KD, et al. Characterization of genetically engineered mouse models carrying Col2a1-cre-induced deletions of Lrp5 and/or Lrp6. Bone Res. 2016;4:15042doi: 10.1038/boneres.2015.42.
Schumacher, C. A., Joiner, D. M., Less, K. D., Drewry, M. O., & Williams, B. O. (2016). Characterization of genetically engineered mouse models carrying Col2a1-cre-induced deletions of Lrp5 and/or Lrp6. Bone research, 415042. https://doi.org/10.1038/boneres.2015.42
Schumacher, Cassie A, et al. "Characterization of genetically engineered mouse models carrying Col2a1-cre-induced deletions of Lrp5 and/or Lrp6." Bone research vol. 4 (2016): 15042. doi: https://doi.org/10.1038/boneres.2015.42
Schumacher CA, Joiner DM, Less KD, Drewry MO, Williams BO. Characterization of genetically engineered mouse models carrying Col2a1-cre-induced deletions of Lrp5 and/or Lrp6. Bone Res. 2016 Mar 01;4:15042. doi: 10.1038/boneres.2015.42. eCollection 2016. PMID: 26962465; PMCID: PMC4772748.
Copy Download .nbib Format: NLM
Mass and thermal diffusivity algorithms: reduced algorithms for mass and thermal diffusivity determinations.

Annals of the New York Academy of Sciences

Banish RM, Albert LB, Pourpoint TL, Alexander JI, Sekerka RF.
PMID: 12446321
Ann N Y Acad Sci. 2002 Oct;974:146-56. doi: 10.1111/j.1749-6632.2002.tb05904.x.

Mass and thermal diffusivity measurements conducted on Earth are prone to contamination by uncontrollable convective contributions to the overall transport. Previous studies of mass and thermal diffusivities conducted on spacecraft have demonstration the gain in precision, and lower absolute...

Cite
Banish RM, Albert LB, Pourpoint TL, et al. Mass and thermal diffusivity algorithms: reduced algorithms for mass and thermal diffusivity determinations. Ann N Y Acad Sci. 2002;974:146-56doi: 10.1111/j.1749-6632.2002.tb05904.x.
Banish, R. M., Albert, L. B., Pourpoint, T. L., Alexander, J. I., & Sekerka, R. F. (2002). Mass and thermal diffusivity algorithms: reduced algorithms for mass and thermal diffusivity determinations. Annals of the New York Academy of Sciences, 974146-56. https://doi.org/10.1111/j.1749-6632.2002.tb05904.x
Banish, R Michael, et al. "Mass and thermal diffusivity algorithms: reduced algorithms for mass and thermal diffusivity determinations." Annals of the New York Academy of Sciences vol. 974 (2002): 146-56. doi: https://doi.org/10.1111/j.1749-6632.2002.tb05904.x
Banish RM, Albert LB, Pourpoint TL, Alexander JI, Sekerka RF. Mass and thermal diffusivity algorithms: reduced algorithms for mass and thermal diffusivity determinations. Ann N Y Acad Sci. 2002 Oct;974:146-56. doi: 10.1111/j.1749-6632.2002.tb05904.x. PMID: 12446321.
Copy Download .nbib Format: NLM
Persistent hiccups associated with intravenous corticosteroid therapy.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases

Hung YM, Miller MA, Patel MM.
PMID: 17041480
J Clin Rheumatol. 2003 Oct;9(5):306-9. doi: 10.1097/01.rhu.0000089792.61349.0c.

Singulata, commonly known as hiccups, have many causes and are most often idiopathic and short-lived. Occasionally, hiccups can be persistent and becoming quite bothersome, distracting, and even disabling. Many medications have been implicated as a cause of hiccups. Although...

Cite
Hung YM, Miller MA, Patel MM. Persistent hiccups associated with intravenous corticosteroid therapy. J Clin Rheumatol. 2003;9(5):306-9doi: 10.1097/01.rhu.0000089792.61349.0c.
Hung, Y. M., Miller, M. A., & Patel, M. M. (2003). Persistent hiccups associated with intravenous corticosteroid therapy. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 9(5), 306-9. https://doi.org/10.1097/01.rhu.0000089792.61349.0c
Hung, Yao-Min, et al. "Persistent hiccups associated with intravenous corticosteroid therapy." Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases vol. 9,5 (2003): 306-9. doi: https://doi.org/10.1097/01.rhu.0000089792.61349.0c
Hung YM, Miller MA, Patel MM. Persistent hiccups associated with intravenous corticosteroid therapy. J Clin Rheumatol. 2003 Oct;9(5):306-9. doi: 10.1097/01.rhu.0000089792.61349.0c. PMID: 17041480.
Copy Download .nbib Format: NLM
(Methanol-κO)(2-methyl-3,5-dinitro-benzoato-κO)triphenyl-tin(IV).

Acta crystallographica. Section E, Structure reports online

Danish M, Ghafoor S, Ahmad N, Starosta W, Leciejewicz J.
PMID: 21754262
Acta Crystallogr Sect E Struct Rep Online. 2011 May 01;67:m519. doi: 10.1107/S1600536811011184. Epub 2011 Apr 07.

In the title complex, [Sn(C(6)H(5))(3)(C(8)H(5)N(2)O(6))(CH(3)OH)], the Sn(IV) ion is coordinated in a slightly distorted trigonal-bipyramidal geometry by three phenyl ligands in the equatorial plane and by a 2-methyl-3,5-dinitro-benzene-carboxyl-ato ligand and a methanol ligand at the apical sites. In the...

Cite
Danish M, Ghafoor S, Ahmad N, et al. (Methanol-κO)(2-methyl-3,5-dinitro-benzoato-κO)triphenyl-tin(IV). Acta Crystallogr Sect E Struct Rep Online. 2011;67:m519doi: 10.1107/S1600536811011184.
Danish, M., Ghafoor, S., Ahmad, N., Starosta, W., & Leciejewicz, J. (2011). (Methanol-κO)(2-methyl-3,5-dinitro-benzoato-κO)triphenyl-tin(IV). Acta crystallographica. Section E, Structure reports online, 67m519. https://doi.org/10.1107/S1600536811011184
Danish, Muhammad, et al. "(Methanol-κO)(2-methyl-3,5-dinitro-benzoato-κO)triphenyl-tin(IV)." Acta crystallographica. Section E, Structure reports online vol. 67 (2011): m519. doi: https://doi.org/10.1107/S1600536811011184
Danish M, Ghafoor S, Ahmad N, Starosta W, Leciejewicz J. (Methanol-κO)(2-methyl-3,5-dinitro-benzoato-κO)triphenyl-tin(IV). Acta Crystallogr Sect E Struct Rep Online. 2011 May 01;67:m519. doi: 10.1107/S1600536811011184. Epub 2011 Apr 07. PMID: 21754262; PMCID: PMC3089075.
Copy Download .nbib Format: NLM
rac-2-Iodo-3,4-dihydro-naphthalen-1(2H)-one.

Acta crystallographica. Section E, Structure reports online

Raza AR, Tahir MN, Sultan A, Danish M, Sohail M.
PMID: 21578887
Acta Crystallogr Sect E Struct Rep Online. 2009 Nov 21;65:o3172. doi: 10.1107/S1600536809049095.

In the title compound, C(10)H(9)IO, the asymmetric unit contains two mol-ecules, in which the iodo-bearing six-membered rings adopt envelope conformations [displacements of the flap atoms = 0.419 (3) and 0.431 (3) Å]. In both mol-ecules, the I atoms are...

Cite
Raza AR, Tahir MN, Sultan A, et al. rac-2-Iodo-3,4-dihydro-naphthalen-1(2H)-one. Acta Crystallogr Sect E Struct Rep Online. 2009;65:o3172doi: 10.1107/S1600536809049095.
Raza, A. R., Tahir, M. N., Sultan, A., Danish, M., & Sohail, M. (2009). rac-2-Iodo-3,4-dihydro-naphthalen-1(2H)-one. Acta crystallographica. Section E, Structure reports online, 65o3172. https://doi.org/10.1107/S1600536809049095
Raza, Abdul Rauf, et al. "rac-2-Iodo-3,4-dihydro-naphthalen-1(2H)-one." Acta crystallographica. Section E, Structure reports online vol. 65 (2009): o3172. doi: https://doi.org/10.1107/S1600536809049095
Raza AR, Tahir MN, Sultan A, Danish M, Sohail M. rac-2-Iodo-3,4-dihydro-naphthalen-1(2H)-one. Acta Crystallogr Sect E Struct Rep Online. 2009 Nov 21;65:o3172. doi: 10.1107/S1600536809049095. PMID: 21578887; PMCID: PMC2971913.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 480 entries